Novel generation of pH indicators for proton magnetic resonance spectroscopic imaging

Journal of Medicinal Chemistry

Volumn 50, Issue 18, 2007, Pages 4539-4542

  Soler Padrós, Jordi ^a   Pérez Mayoral, Elena ^a   Domínguez, Laura ^b   López Larrubia, Pilar ^c   Soriano, Elena ^c   Marco Contelles, José Luis ^b   Cerdán, Sebastián ^c   Ballesteros, Paloma ^a  

^a UNIVERSIDAD NACIONAL DE EDUCACIÓN A DISTANCIA   (Spain)

^b INSTITUTO DE QUÍMICA ORGÁNICA GENERAL   (Spain)

^c INSTITUTO DE INVESTIGACIONES BIOMÉDICAS ALBERTO SOLS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

1,3 DIIMIDAZOL 1 YLDEOXYGLYCEROL; 1,OMEGA DI 1H IMIDAZOLE; 2,3 DIHYDROXYBUTANE 1,4 DIYL DI 1H IMIDAZOLIUM; 2,3,4,5 TETRAHYDROXYHEXANE 1,6 DIYL DI 1H IMIDAZOLIUM; IMIDAZOLE DERIVATIVE; INDICATOR; MANNITOL; THREITOL; TOLUENESULFONIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG SYNTHESIS; GLIOBLASTOMA; GLIOMA CELL; MOLECULAR IMAGING; NONHUMAN; PKA; POSITRON EMISSION TOMOGRAPHY; PROTON NUCLEAR MAGNETIC RESONANCE; RAT; SIGNAL NOISE RATIO;

ANIMALS; BRAIN CHEMISTRY; CELL LINE, TUMOR; EXTRACELLULAR SPACE; HYDROGEN-ION CONCENTRATION; IMIDAZOLES; INDICATORS AND REAGENTS; MAGNETIC RESONANCE SPECTROSCOPY; NEOPLASMS; RATS; RATS, WISTAR; STEREOISOMERISM;

EID: 34548450919     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm070044j     Document Type: Article

References (25)

1. Grimmett, M. R. Imidazole and Benzimidazole Synthesis; Academic Press: London, 1997.
2. Al Mourabit, A; Poitier, P. Sponge's Molecular Diversity Through the Ambivalent Reactivity of 2-Aminoimidazole: A Universal Chemical Pathway to the Oroidin-Based Pyrrole-Imidazole Alkaloids and Their Palau'amine Congeners. Eur. J. Org. Chem. 2001, 237-243.
3. Pindur, U.; Lemster, T. Advances in Marine Natural Products of the Indole and Annelated Indole Series: Chemical and Biological Aspects. Curr. Med. Chem. 2001, 8, 1681-1698.
4. Aboagye, E. O.; Kelson, A. B.; Tracy, M.; Workman, P. Preclinical Development and Current Status of the Fluorinated 2-Nitroimidazole Hypoxia Probe N-(2-Hydroxy-3,3,3-trifluoropropyl)-2-(2-nitro-1-imidazolyl) Acetamide (SR 4554, CRC 94/17): A Non Invasive Diagnostic Probe for the Measurement of Tumor Hypoxia by Magnetic Resonance Spectroscopy and Imaging, and by Positron Emission Tomography. Anti-Cancer Drug Des. 1998, 13, 703-730.
5. Seddon, B. M.; Payne, G. S.; Simmons, L.; Ruddle, R.; Grimshaw, R.; Tan, S.; Turner, A.; Raynaud, F.; Halbert, G.; Leach, M. O.; Judson, I.; Workman, P. A Phase I Study of SR-4554 via Intravenous Administration of Tumor Hypoxia by Magnetic Resonance Spectroscopy in Patients with Malignancy. Clin. Cancer Res. 2003, 9, 5101-5112.
6. 1H NMR Probes for Intracellular pH. Bioorg. Med. Chem. Lett. 1992, 2, 1717-1722.
7. 1H NMR Probes for the Determination of Intracellular pH, Extracellular pH and Cell Volume. Bioorg. Med. Chem. 1994, 2, 305-314.
8. Zaderenko, P.; Gil, M. S.; Ballesteros, P.; Cerdán, S. Synthesis and Regioselective Hydrolysis of 2-Imidazol-1-ylsuccinic Esters. J. Org. Chem. 1994, 59, 6268-6273.
9. Zaderenko, P.; López, M. C.; Ballesteros, P. Addition of Azoles and Amines to Unsymmetrical Fumaric Esters. J. Org. Chem. 1996, 61, 6825-6828.
10. 1H MRSI. J. Magn. Reson. Med. 1999, 41, 743-750.
11. 1H Magnetic Resonance Spectroscopy: Comparison with Maps of Other Metabolites. Cancer Res. 2001, 61, 6524-6531.
12. Bhujwala, Z.; Artemov, D.; Ballesteros, P.; Cerdán, S.; Gillies, R.; Solaiyappan, M. Combined Vascular and Extracellular pH Imaging of Solid Tumors. NMR Biomed. 2002, 15, 114-119.
13. Wike-Hooley, J. L.; Haveman, J.; Reinhold, H. S. The Relevance of Tumor pH to the Treatment of Malignant Disease. Radiother. Oncol. 1984, 2, 343-366.
14. 31P MRS Measurement of Extracellular pH of Tumor Using 3-Aminopropylphosphonate. Am. J. Physiol. 1994, 267, C195-C203.
15. Cairns, R.; Papandreou, I.; Denko, N. Overcoming Physiologic Barriers to Cancer Treatment by Molecularly Targeting the Tumor Microenvironment. Mol. Cancer Res. 2006, 4, 61-70.
16. Wong, P.; Lee, C.; Tannock, I. F. Reduction of Intracellular pH as a Strategy to Enhance the pH-Dependent Cytotoxic Effects of Melphalan for Human Breast Cancer Cells. Clin. Cancer Res. 2005, 11, 3553-3557.
17. Raghunand, N.; He, X.; van Sluis, R.; Mahoney, B.; Baggett, B.; Taylor, C. W.; Paine-Murrieta, G.; Roe, D.; Bhujwalla, Z. M.; Gillies, R. J. Enhancement of Chemotherapy by Manipulation of Tumour pH, Br. J. Cancer 1999, 80, 1005-1011.
18. Engin, K.; Leepers, D. B.; Thistlethwaite, A. J.; Tupchon, L.; McFarlane, J. D. Tumor Extracellular pH as a Prognostic Factor in Thermoradiotherapy. Int. J. Radiat. Oncol., Biol., Phys. 1994, 29, 125-132.
19. López-Larrubia, P.; García-Amo, M.; Mayoral, E. P.; Gillies, R. J.; Cerdán, S.; Ballesteros, P. τ-Regioselective Addition of (-)-N(α)-tert-Butoxycarbonyl-L-histidine Methyl Ester to Diethyl Fumarate. ARKIVOC 2004, 26-31.
20. Scheithauer, S.; Otto, R.; Reitenbach, U.; Friese, J. DD 284225, 1990. The O-stearoyl derivative of compound 5 has been described in a study directed to the synthesis of dicephalic (two-headed) surfactants: Sommerdijk, N. A. J. M.; Hoeks, T. L.; Booy, K. J.; Feiters, M. C.; Nolte, R. J. M.; Zwanenburg, B. Dicephalic Surfactants. Chem. Commun. 1998, 743-744.
21. 18F]-fluoromisonidazole). Pharm. Res. 1994, 11, 466-469.
22. Brown, J. M.; Dayrit, F. M.; Sinou, D. Chiral Ligands for Organometallic Catalysis Containing Two Dioxolane Rings. J. Chem. Soc., Perkin Trans. 2 1987, 91-95.
23. Acton, E. M.; Keyanpour-Rad, M.; Christensen, J. E.; Tong, H. H.; Kwok, R. P.; Goodman, L. Potential Antitumor Agents. Some 1,6-Disubstituted Galactitol and Mannitol Derivatives. Carbohydr. Res. 1972, 22, 477-486.
24. Toldy, L.; Vargha, L. Benzylidene Derivatives of L-iditol. Chem. Ber. 1959, 92, 2694-2700.
25. Soriano, E.; Ballesteros, P.; Cerdán, S. Computational Determination of pKa values. A Comparison of Different Theoretical Approaches and a Novel Procedure. THEOCHEM 2004, 684, 121-128.